NDC 0069-1975-40
Vyndaqel 20 mg/1
tafamidis meglumine · CAPSULE, LIQUID FILLED
Vyndaqel (tafamidis meglumine) is an oral medication taken as a capsule that is used to treat a rare condition called transthyretin amyloidosis, which affects the heart and nervous system. It works by stabilizing a protein in the body that would otherwise accumulate and cause organ damage.
Key Facts
- Brand Name
- Vyndaqel
- Generic Name
- tafamidis meglumine
- NDC Code (Package)
0069-1975-40- NDC Code (Product)
0069-1975- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 20 mg/1
- Dosage Form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Marketing Status
- Application #
- NDA211996
- Marketing Start
- 05/16/2019
Recall History
No Recall HistoryView Full Drug Page
Vyndaqel — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.